ECNS - ETF AI Analysis
Top Page
iShares MSCI China Small-Cap ETF (ECNS)
Rating:56Neutral
Price Target:―
Positive Factors
Strong Leading Holdings
Several of the largest positions have shown strong gains this year, helping support the fund despite broader weakness.
Broad Sector Diversification
The ETF spreads its investments across many sectors, including health care, industrials, technology, and consumer-related areas, which helps reduce reliance on any single industry.
Focused Exposure to Chinese Small Caps
The fund offers targeted access to smaller Chinese companies, giving investors a way to tap into potential growth that may not be captured by large-cap China funds.
Negative Factors
Recent Weak Performance
The ETF has delivered weak returns over the past year-to-date and recent months, which may concern investors looking for near-term strength.
High Geographic Concentration
With most assets tied to Hong Kong-listed companies and limited exposure elsewhere, the fund is heavily exposed to the risks of a single market.
Relatively High Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which means more of the returns are used to cover fees instead of going to investors.
ECNS vs. SPDR S&P 500 ETF (SPY)
AUM64.91M
RegionAsia-Pacific
Expense Ratio0.59%
Beta0.74
IssueriShares
Inception DateSep 28, 2010
Dividend Yield6.62%
Asset ClassEquity
Index TrackedMSCI China Small Cap
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume6,905
30 Day Avg. Volume13,459
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering235
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ECNS Summary
The iShares MSCI China Small-Cap ETF (ECNS) tracks the MSCI China Small Cap index and focuses on smaller companies in China and Hong Kong. It spreads investments across many sectors, including health care, industrials, and technology, with holdings like Kingboard Holdings and Zai Lab. Someone might consider this ETF if they want growth potential from up-and-coming Chinese businesses and extra diversification beyond large, well-known firms. However, small-cap stocks in a single country can be very volatile, so the ETF’s price can move up and down sharply with changes in China’s economy and markets.
How much will it cost me?The iShares MSCI China Small-Cap ETF (ECNS) has an expense ratio of 0.59%, which means you’ll pay $5.90 per year for every $1,000 invested. This is higher than average because the fund is actively managed to focus on small-cap stocks in China, which requires more research and management compared to passively managed funds. It’s designed for investors seeking growth opportunities in a niche market.
What would affect this ETF?The iShares MSCI China Small-Cap ETF (ECNS) could benefit from China's economic growth and government support for innovation, especially in sectors like healthcare and technology, which make up a significant portion of its holdings. However, risks include potential regulatory changes in China, global economic uncertainty, and the volatility of small-cap stocks, which are more sensitive to market fluctuations. Investors should also consider how geopolitical tensions or shifts in trade policies might impact the ETF's performance.
ECNS Top 10 Holdings
ECNS is a pure China small-cap play, with health care and industrial names setting the tone. Keymed Biosciences and Zai Lab are rising on revenue growth but still feel like cash-burning lab projects, adding volatility as they struggle toward profitability. On the industrial side, Kingboard Holdings and Dongyue Group are more steady but have recently lost some steam, softening the fund’s momentum. JOYY and Meitu in communication services bring a mixed, more speculative flavor, leaving the ETF driven by China’s homegrown innovators but weighed down by their uneven execution.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Kingboard Holdings | 2.12% | $1.37M | HK$46.62B | 105.31% | 69 Neutral | |
| Minth Group | 1.68% | $1.08M | HK$31.98B | 68.27% | 71 Outperform | |
| China Everbright | 1.56% | $1.00M | HK$31.94B | 23.78% | 66 Neutral | |
| TCL Electronics Holdings | 1.38% | $893.84K | HK$40.89B | 36.00% | 66 Neutral | |
| Zai Lab Ltd | 1.32% | $851.16K | HK$16.35B | -50.94% | 42 Neutral | |
| Meitu | 1.30% | $837.06K | HK$20.64B | -36.09% | 66 Neutral | |
| China Medical System Holdings | 1.26% | $811.00K | HK$29.45B | 3.56% | 65 Neutral | |
| Dongyue Group Limited | 1.25% | $810.46K | HK$19.64B | 11.52% | 62 Neutral | |
| Keymed Biosciences, Inc. | 1.25% | $806.20K | HK$21.13B | 18.81% | 41 Neutral | |
| Atour Lifestyle Holdings | 1.20% | $776.60K | $4.86B | 1.24% | 75 Outperform |
ECNS Technical Analysis
Negative
―
Price Trends
29.51
Negative
31.25
Negative
32.65
Negative
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ECNS, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 28.60, equal to the 50-day MA of 29.51, and equal to the 200-day MA of 32.65, indicating a neutral trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ECNS.
ECNS Peer Comparison
Comparison Results
Performance Comparison
ECNS
iShares MSCI China Small-Cap ETF
28.86
-3.34
-10.37%
MCHI
iShares MSCI China ETF
―
―
―
FXI
iShares China Large-Cap ETF
―
―
―
PGJ
Invesco Golden Dragon China Etf
―
―
―
FCA
First Trust China AlphaDEX Fund
―
―
―
MJSC
MUFG Japan Small Cap Active ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents